Waverly Advisors LLC acquired a new stake in Molina Healthcare, Inc (NYSE:MOH – Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 4,466 shares of the company’s stock, valued at approximately $595,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MOH. Torren Management LLC purchased a new position in shares of Molina Healthcare during the 4th quarter valued at $26,000. MUFG Securities EMEA plc purchased a new stake in shares of Molina Healthcare during the second quarter worth $48,000. Quarry LP purchased a new stake in shares of Molina Healthcare during the fourth quarter worth $32,000. Triumph Capital Management boosted its position in Molina Healthcare by 4,625.0% during the fourth quarter. Triumph Capital Management now owns 189 shares of the company’s stock valued at $33,000 after purchasing an additional 185 shares during the last quarter. Finally, Physician Wealth Advisors Inc. boosted its position in Molina Healthcare by 1,250.0% during the first quarter. Physician Wealth Advisors Inc. now owns 216 shares of the company’s stock valued at $29,000 after purchasing an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.
Molina Healthcare Trading Up 0.2%
Shares of NYSE:MOH opened at $196.10 on Monday. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $10.24 billion, a PE ratio of -1,089.40, a P/E/G ratio of 28.02 and a beta of 0.75. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $244.89. The firm has a fifty day moving average price of $207.67 and a 200 day moving average price of $177.56.
Analyst Ratings Changes
A number of research analysts have commented on MOH shares. TD Cowen boosted their target price on Molina Healthcare from $163.00 to $230.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Weiss Ratings lowered Molina Healthcare from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, July 24th. Robert W. Baird lifted their price target on Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Wells Fargo & Company lowered their price target on Molina Healthcare from $235.00 to $220.00 and set an “equal weight” rating for the company in a research note on Tuesday, July 28th. Finally, Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective on the stock in a report on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $202.44.
View Our Latest Analysis on Molina Healthcare
Insider Transactions at Molina Healthcare
In related news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the sale, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.44% of the company’s stock.
Molina Healthcare Profile
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
Read More
- Five stocks we like better than Molina Healthcare
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
